• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠肺炎中的晚期糖基化终产物(RAGE)受体途径。

The receptor for advanced glycation end product (RAGE) pathway in COVID-19.

机构信息

Ondokuz Mayis University, Faculty of Medicine, Department of Internal Medicine, Samsun, Turkey.

Amasya University, Faculty of Medicine, Department of Infection Disease, Amasya, Turkey.

出版信息

Biomarkers. 2021 Mar;26(2):114-118. doi: 10.1080/1354750X.2020.1861099. Epub 2021 Jan 13.

DOI:10.1080/1354750X.2020.1861099
PMID:33284049
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7814566/
Abstract

INTRODUCTION

Coronavirus disease-2019 (COVID-19) with lung involvement frequently causes morbidity and mortality. Advanced age appears to be the most important risk factor. The receptor for advanced glycation end-product (RAGE) pathway is considered to play important roles in the physiological aging and pathogenesis of lung diseases. This study aimed to investigate the possible relationship between COVID-19 and RAGE pathway.

MATERIALS AND METHODS

This study included 23 asymptomatic patients and 35 patients with lung involvement who were diagnosed with COVID-19 as well as 22 healthy volunteers. Lung involvement was determined using computed tomography. Serum soluble-RAGE (sRAGE) levels were determined using enzyme-linked immunosorbent assay.

RESULTS

The sRAGE levels were significantly higher in the asymptomatic group than in the control group. Age, fibrinogen, C-reactive protein, and ferritin levels were higher and the sRAGE level was lower in the patients with lung involvement than in the asymptomatic patients.

CONCLUSIONS

In this study, patients with high sRAGE levels were younger and had asymptomatic COVID-19. Patients with low sRAGE levels were elderly patients with lung involvement, which indicates that the RAGE pathway plays an important role in the aggravation of COVID-19.

摘要

简介

新冠肺炎(COVID-19)常导致肺部受累,引起发病率和死亡率。高龄似乎是最重要的危险因素。晚期糖基化终产物(RAGE)途径受体被认为在肺部疾病的生理衰老和发病机制中发挥重要作用。本研究旨在探讨 COVID-19 与 RAGE 途径之间的可能关系。

材料和方法

本研究纳入了 23 例无症状患者和 35 例肺部受累的 COVID-19 患者,以及 22 名健康志愿者。通过计算机断层扫描确定肺部受累情况。采用酶联免疫吸附试验测定血清可溶性 RAGE(sRAGE)水平。

结果

无症状组的 sRAGE 水平明显高于对照组。与无症状患者相比,肺部受累患者的年龄、纤维蛋白原、C 反应蛋白和铁蛋白水平较高,sRAGE 水平较低。

结论

在本研究中,高 sRAGE 水平的患者年龄较小且患有无症状 COVID-19。低 sRAGE 水平的患者为老年肺部受累患者,这表明 RAGE 途径在 COVID-19 的加重中起重要作用。

相似文献

1
The receptor for advanced glycation end product (RAGE) pathway in COVID-19.新冠肺炎中的晚期糖基化终产物(RAGE)受体途径。
Biomarkers. 2021 Mar;26(2):114-118. doi: 10.1080/1354750X.2020.1861099. Epub 2021 Jan 13.
2
Danger-associated molecular pattern molecules and the receptor for advanced glycation end products enhance ANCA-induced responses.危险相关分子模式分子和晚期糖基化终产物的受体增强了抗中性粒细胞胞浆抗体诱导的反应。
Rheumatology (Oxford). 2022 Feb 2;61(2):834-845. doi: 10.1093/rheumatology/keab413.
3
Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.高水平的可溶性晚期糖基化终产物受体和低水平的细胞外新鉴定的晚期糖基化终产物受体与 1 型糖尿病患者的降脂药物有关:一项比较横断面研究。
Lipids Health Dis. 2020 Oct 14;19(1):223. doi: 10.1186/s12944-020-01397-2.
4
Advanced glycation end products (AGE) and receptor for AGE (RAGE) in patients with active tuberculosis, and their relationship between food intake and nutritional status.活动性结核病患者中的晚期糖基化终产物 (AGE) 和 AGE 受体 (RAGE),及其与饮食摄入和营养状况的关系。
PLoS One. 2019 Mar 14;14(3):e0213991. doi: 10.1371/journal.pone.0213991. eCollection 2019.
5
Leptin and advanced glycation end products receptor (RAGE) in tuberculosis patients.结核病人瘦素与晚期糖基化终末产物受体(RAGE)。
PLoS One. 2021 Jul 2;16(7):e0254198. doi: 10.1371/journal.pone.0254198. eCollection 2021.
6
Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study.COPD 患者中晚期糖基化终产物可溶性受体:与肺气肿和慢性肺源性心脏病的关系:一项病例对照研究。
Respir Res. 2011 Mar 30;12(1):37. doi: 10.1186/1465-9921-12-37.
7
Circulating levels of soluble receptor for advanced glycation end product are inversely associated with vascular calcification in patients on haemodialysis independent of S100A12 (EN-RAGE) levels.在血液透析患者中,可溶性晚期糖基化终产物受体的循环水平与血管钙化呈负相关,与 S100A12(EN-RAGE)水平无关。
Nephrology (Carlton). 2013 Dec;18(12):777-82. doi: 10.1111/nep.12166.
8
Circulating soluble RAGE and cell surface RAGE on peripheral blood mononuclear cells in healthy children.健康儿童外周血单个核细胞上的循环可溶性晚期糖基化终末产物受体及细胞表面晚期糖基化终末产物受体
J Pediatr Endocrinol Metab. 2018 Jun 27;31(6):649-654. doi: 10.1515/jpem-2017-0512.
9
Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease.在患有炎症性肠病的犬类中,抗炎性诱饵受体可溶性晚期糖基化终末产物受体(sRAGE)的全身水平降低。
Vet Immunol Immunopathol. 2014 Oct 15;161(3-4):184-92. doi: 10.1016/j.vetimm.2014.08.003. Epub 2014 Aug 13.
10
The clinical significance of circulating soluble RAGE in patients with severe sepsis.严重脓毒症患者循环中可溶性晚期糖基化终末产物受体的临床意义
J Trauma Acute Care Surg. 2015 Jun;78(6):1086-93; discussion 1093-4. doi: 10.1097/TA.0000000000000651.

引用本文的文献

1
Immunity and Coagulation in COVID-19.新型冠状病毒肺炎中的免疫与凝血。
Int J Mol Sci. 2024 Oct 19;25(20):11267. doi: 10.3390/ijms252011267.
2
Redox Biomarkers - An Effective Tool for Diagnosing COVID-19 Patients and Convalescents.氧化还原生物标志物——诊断新冠肺炎患者和康复者的有效工具。
J Inflamm Res. 2024 Apr 26;17:2589-2607. doi: 10.2147/JIR.S456849. eCollection 2024.
3
Quantitative multiorgan proteomics of fatal COVID-19 uncovers tissue-specific effects beyond inflammation.致命性 COVID-19 的多器官定量蛋白质组学研究揭示了炎症之外的组织特异性效应。
EMBO Mol Med. 2023 Sep 11;15(9):e17459. doi: 10.15252/emmm.202317459. Epub 2023 Jul 31.
4
Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance.新冠病毒相关急性呼吸窘迫综合征的细胞和分子特征:治疗意义
J Inflamm (Lond). 2023 Mar 20;20(1):11. doi: 10.1186/s12950-023-00333-2.
5
Negative Effects of Chronic High Intake of Fructose on Lung Diseases.慢性过量摄入果糖对肺部疾病的负面影响。
Nutrients. 2022 Oct 1;14(19):4089. doi: 10.3390/nu14194089.
6
The potential molecular implications of adiponectin in the evolution of SARS-CoV-2: Inbuilt tendency.脂联素在新冠病毒进化中的潜在分子影响:内在倾向。
J King Saud Univ Sci. 2022 Nov;34(8):102347. doi: 10.1016/j.jksus.2022.102347. Epub 2022 Sep 30.
7
The role of berberine in Covid-19: potential adjunct therapy.小檗碱在新冠病毒肺炎中的作用:一种潜在的辅助治疗方法。
Inflammopharmacology. 2022 Dec;30(6):2003-2016. doi: 10.1007/s10787-022-01080-1. Epub 2022 Oct 2.
8
RAGE pathway activation and function in chronic kidney disease and COVID-19.晚期糖基化终末产物受体(RAGE)通路在慢性肾脏病和2019冠状病毒病(COVID-19)中的激活与功能
Front Med (Lausanne). 2022 Aug 9;9:970423. doi: 10.3389/fmed.2022.970423. eCollection 2022.
9
Clinical Utility of Circulating Pneumoproteins as Diagnostic and Prognostic Biomarkers in COVID-19: A Systematic Review and Meta-analysis.循环肺炎蛋白作为COVID-19诊断和预后生物标志物的临床应用:系统评价和荟萃分析
Infect Dis Ther. 2022 Oct;11(5):1981-1998. doi: 10.1007/s40121-022-00686-w. Epub 2022 Aug 25.
10
The Remarkable Roles of the Receptor for Advanced Glycation End Products (RAGE) and Its Soluble Isoforms in COVID-19: The Importance of RAGE Pathway in the Lung Injuries.晚期糖基化终末产物受体(RAGE)及其可溶性异构体在新型冠状病毒肺炎(COVID-19)中的显著作用:RAGE信号通路在肺损伤中的重要性
Indian J Clin Biochem. 2023 Apr;38(2):159-171. doi: 10.1007/s12291-022-01081-5. Epub 2022 Aug 18.

本文引用的文献

1
Age-Related Differences in Immunological Responses to SARS-CoV-2.年龄相关的对 SARS-CoV-2 的免疫反应差异。
J Allergy Clin Immunol Pract. 2020 Nov-Dec;8(10):3251-3258. doi: 10.1016/j.jaip.2020.08.026. Epub 2020 Aug 27.
2
Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week.SARS-CoV-2 与肾素血管紧张素系统相互作用的临床意义:美国心脏病学会评论专题周报。
J Am Coll Cardiol. 2020 Jun 23;75(24):3085-3095. doi: 10.1016/j.jacc.2020.04.028. Epub 2020 Apr 16.
3
[From SARS to COVID-19: pathogens, receptor, pathogenesis and principles of the treatment].从非典到新冠:病原体、受体、发病机制及治疗原则
Zhonghua Bing Li Xue Za Zhi. 2020 Jun 8;49(6):647-652. doi: 10.3760/cma.j.cn112151-20200318-00220.
4
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
5
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2.全长人血管紧张素转化酶 2 识别 SARS-CoV-2 的结构基础。
Science. 2020 Mar 27;367(6485):1444-1448. doi: 10.1126/science.abb2762. Epub 2020 Mar 4.
6
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征:描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
7
Is RAGE the receptor for inflammaging?RAGE是炎症衰老的受体吗?
Aging (Albany NY). 2019 Sep 8;11(17):6620-6621. doi: 10.18632/aging.102256.
8
The receptor for advanced glycation end-products (RAGE) is an important pattern recognition receptor (PRR) for inflammaging.晚期糖基化终产物受体(RAGE)是炎症老化的重要模式识别受体(PRR)。
Biogerontology. 2019 Jun;20(3):279-301. doi: 10.1007/s10522-019-09808-3. Epub 2019 Apr 9.
9
RAGE inhibition reduces acute lung injury in mice.RAGE 抑制减轻了小鼠的急性肺损伤。
Sci Rep. 2017 Aug 3;7(1):7208. doi: 10.1038/s41598-017-07638-2.
10
All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses.肺部疾病中的所有“愤怒”:晚期糖基化终产物受体(RAGE)是肺部炎症反应的主要介质。
Paediatr Respir Rev. 2017 Jun;23:40-49. doi: 10.1016/j.prrv.2017.03.012. Epub 2017 Mar 18.